Faes Farma, S.A. (BME: FAE)

Market Cap	1.13B
Revenue (ttm)	493.75M
Net Income (ttm)	97.26M
Shares Out	311.25M
EPS (ttm)	0.31
PE Ratio	11.66
Forward PE	12.63
Dividend	0.16 (4.26%)
Ex-Dividend Date	Jul 4, 2024

Volume	32,964
Open	3.630
Previous Close	3.640
Day's Range	3.585 - 3.630
52-Week Range	2.865 - 3.830
Beta	0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,762
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2023, CAF's revenue was 3.83 billion, an increase of 20.88% compared to the previous year's 3.17 billion. Earnings were 89.16 million, an increase of 70.84%.